Daniel Bensen, Chief Operating Officer at Tyra Biosciences, Inc. (TYRA), sold 179,312 shares at $18.09 ($3.0M) on 2024-02-06, disclosed to the SEC on 2024-02-06.
Scheduled sale ($3.0M) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.31 | 73,093 | $1.2M | 40.0% |
| 2 | $16.31 | 73,093 | $1.2M | 40.0% |
| 3 | $17.04 | 2,300 | $39K | 1.3% |
| 4 | $18.09 | 15,413 | $279K | 9.4% |
| 5 | $18.09 | 15,413 | $279K | 9.4% |
| Total | $16.63 avg | 179,312 |
| $3.0M |
| 100% |
| Filing → |
| TYRA | SELL | 2025-12-16 | $181K | — | Filing → |
| TYRA | SELL | 2025-11-19 | $4.1M | — | Filing → |
| TYRA | SELL | 2025-11-17 | $4.2M | — | Filing → |